Upcoming CPD Sessions

CV Risk Reduction in Diabetes (SGLT2 inhibitors/GLP-1 Receptor Agonists in Patients with DM and CVD)
June 3, 2020 • 7-9PM Eastern Time
Speaker Dr. Richard Choi, moderator Dr. Sheldon Tobe

Upon completion of this activity, participants should be able to:

• Describe the patient who should be treated with an SGLT2i or GLP-1 RA.
• Explain the rational for this treatment and the potential benefits.
• Describe the steps for initiating and monitoring therapy for patients with diabetes.
  

Accredited for 3 credits per hour, total of maximum 6 credits.

FAQs

• How can I contact the organizer with any questions?
To contact the organizer, email: Diane Hua-Stewart at diane.hua@sunnybrook.ca.

• To learn more:
Please visit the event website: https://www.cchangeguidelines.com/